Dr. Hilary Marusak Director Division of Cannabinoids in Neurodevelopment @ Wayne State University School of Medicine – Budgets Cuts Make Research Under Presidential EO Moot

Detroit Free Press At first glance, President Donald Trump’s Dec. 18 executive order reclassifying cannabis as a Schedule III substance might seem like a win for medical cannabis. But for thousands of patients and researchers, this policy gesture changes little. Since 1970, cannabis has been classified as Schedule I — the same federal category as heroin and LSD — meaning […]